210 filings
Page 3 of 11
8-K
f6mtqkgvl228xbs
1 Oct 21
Amendments to Articles of Incorporation or Bylaws
5:29pm
8-K
xwmgem fvs52y6
22 Sep 21
Hancock Jaffe Announces Corporate Rebranding to Reflect Prioritization of its Development Pipeline on Venous Disease Programs
8:15am
8-K
8be8z5wm ur54a76g
8 Sep 21
Entry into a Material Definitive Agreement
4:49pm
424B5
qpsp5q
8 Sep 21
Prospectus supplement for primary offering
4:43pm
8-K
04e1k8q4nkey9ydn1fa
12 Aug 21
Entry into a Material Definitive Agreement
5:28pm
424B5
rbnk1019 fzw7
12 Aug 21
Prospectus supplement for primary offering
5:26pm
424B3
icoh bz3b
6 Aug 21
Prospectus supplement
4:31pm
S-8
goj42ey lnpyawdy
26 May 21
Registration of securities for employees
5:13pm
EFFECT
q5fje7korbylvi8qt
7 May 21
Notice of effectiveness
12:15am
POS AM
e0w qrqe4xj2nn
30 Apr 21
Prospectus update (post-effective amendment)
9:15am
8-K
yv1 uomyuj
24 Feb 21
Departure of Directors or Certain Officers
5:15pm
8-K
gsmek9pjfbx 9v5utj
12 Feb 21
Hancock Jaffe Laboratories Announces Pricing of Upsized
5:05pm
424B4
u6rcnfb
10 Feb 21
Prospectus supplement with pricing info
12:00am
EFFECT
bklvazb aitmtrb4
9 Feb 21
Notice of effectiveness
12:15am
S-1MEF
nau2p1mzguea
8 Feb 21
Registration of additional securities for an S-1
9:56pm
FWP
01zxps5hzd0zhxtcc
5 Feb 21
Free writing prospectus
4:47pm